Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS
· Delayed Price · Currency is USD
0.0418
-0.0051 (-10.87%)
Jun 30, 2025, 3:20 PM EDT
Inhibitor Therapeutics Employees
As of December 31, 2024, Inhibitor Therapeutics had 9 total employees, including 3 full-time and 6 part-time employees. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$547,889
Market Cap
8.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
American Oncology Network | 1,914 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
Inhibitor Therapeutics News
- 7 months ago - Complement Inhibitor Therapeutics Pipeline Developments Research Report 2024 - GlobeNewsWire
- 8 months ago - Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight - GlobeNewsWire
- 11 months ago - Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan - GlobeNewsWire
- 1 year ago - Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board - PRNewsWire
- 1 year ago - Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University - PRNewsWire